Glick Eye Institute designed to mesh architectural styles, ophthalmology researchers
The new home for the Eugene and Marilyn Glick Eye Institute that’s rising from the ground at IUPUI must do a lot
of things well.
Health Care & Life Sciences
Articles
TAYLOR: Reform will drive demand for health care facilities
There has been a noticeable uptick in the level of health care real estate development activity this year.
Sebelius warns states to check WellPoint hikes
The Obama administration has asked state regulators to double-check premium hikes from Indianapolis-based health insurer WellPoint
Inc. after an audit found problems with proposed California increases.
Wishard Hospital project is life blood to contractors
Replacing the existing Wishard Memorial Hospital is so critical to the well-being of the sickly construction sector that one
industry official likens the project to a "lifeline."
Lilly sues to block copy of Evista osteoporosis drug
Watson Pharmaceuticals filed for FDA approval to sell a low-cost version of Eli Lilly and Co.’s osteoporosis medicine. Indianapolis-based
Lilly is seeking a court order that would block approval until three of its patents expire in 2017.
Clarian hospital system to adopt IU name
Clarian will become Indiana University Health early next year in a bet the IU brand carries more punch statewide and nationally.
Marketing experts: Clarian will get boost from IU name
The Indianapolis-based hospital system, which has 16 hospitals as far afield as LaPorte, Hartford City and Paoli, can
now associate with all its facilities the name of the school that trains the majority of doctors and nurses throughout the
state.
New federal funds come with big goals
Indiana has now received nearly $50 million in federal bucks to digitize health care around the state. But the latest grant—$16
million to the Indiana Health Information Exchange—comes with specific, ambitious goals for health care providers.
Central Indiana gets $16M in health IT stimulus
The central Indiana area has been selected as one of 15 communities that will share in $220 million worth of grants for pilot
projects to test health-care information technology.
Wishard Foundation appoints new leader
Ernest Vargo II’s Vargo’s top priority will be guiding the foundation’s $50 million capital campaign for the construction
of the new, $754 million Wishard Hospital.
Anthem Blue Cross withdraws big California rate hike
Anthem Blue Cross withdrew plans to raise health insurance rates for Californians by as much as 39 percent after an independent
audit determined the company’s justification for raising premiums was based on flawed data.
Startup sees big potential for ‘ouchless’ medical tests
Companion Diagnostics wants to detect early warning signs of chronic diseases.
Closing of Purdue’s Chao Center is setback for BioCrossroads
The university is hoping to find a private company to take over the 5-year-old facility, which formulated and manufactured
small batches of drugs used in clinical trials.
Medco Health profits climb as it adds big clients
Medco, which operates a major pharmacy and distribution center in Whitestown, got a boost from higher prices on brand-name
drugs and from greater sales of more profitable generic drugs.
WellPoint profits rise, beat analysts’ expectations
The Indianapolis-based health insurer was helped in first quarter by a mild flu season, but it now expects to lose nearly
700,000 customers by year end.
Reform to accelerate health care costs
Medicare actuary Richard Foster estimated the new law would raise overall health care spending by an additional $311 million
over current law—more than when he first examined the legislation in December.
WellPoint to adhere to new rescission rules early
The Indianapolis-based health insurer announced Tuesday afternoon it will be the first company to adopt stricter standards
on canceling
policies, which are contained in the health reform bill passed in March.
Chao exit hurts drug development industry
Purdue University’s decision to close the Chao Center in West Lafayette is a setback for Indiana’s effort to grow
a vibrant contract drug manufacturing sector. But it’s just the latest in a series of unexpected changes—not all for
the worse—since Indianapolis-based BioCrossroads launched a contract drug manufacturing initiative in late 2007.
Judge rejects Guidant’s defibrillator plea deal
A federal judge has rejected Guidant Corp.'s guilty plea to charges it hid defects in heart defibrillators, after some
doctors and patients complained about the $296 million deal.
Purdue drug maker closing its doors after 5 years
The Purdue Research Foundation says the Chao Center for Industrial Pharmacy and Contract Manufacturing was unable to become
self-sustaining in part because of the recession.